TNFSF10 and cancer: Despite the rise of controversial evidence on the pivotal role of the DR4 receptor in apoptosis induction by TRAIL in some types of cancer [4,5], the DR5 receptor is traditionally considered more potent and crucial for triggering programmed cell death upon TRAIL binding.